Evidence map›Paper›PMID 40715659›Full record

ArticleNature immunology2025

The transcription complex p52-ETS1 is essential for germinal center formation.

Dhakshayini Morgan, Biyan Zhang, Kerem Fidan, Wenfai Pan, Thamil Selvan Vaiyapuri, Anandhkumar Raju, Dorcas Hei, Ting Yi See, Ita Novita Sari, Jun Wei Chan and 22 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Dhakshayini Morgan *Laboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Biyan Zhang *Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.
Kerem FidanLaboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Wenfai PanFaculty of Health Sciences, University of Macau, Taipa, China.
Thamil Selvan VaiyapuriLaboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Anandhkumar RajuLaboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Dorcas HeiLaboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Ting Yi SeeSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.
Ita Novita SariLaboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Jun Wei ChanLaboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Prativa MajeeLaboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.
Akhila BalachanderSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.
Jiabo YuDepartment of Microbiology and Immunology, Immunology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Ada Hang-Heng WongLaboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore.ORCID http://orcid.org/0000-0002-5960-9940
Michelle Meng Huang MokCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Shi Hui FooSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.
Wei Lin TangSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.
Nicholas AngSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.
Ivan TanSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.
Yan Fen PengCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Patrick JaynesCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Shengli XuSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.
Gourisankar GhoshDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, CA, USA.ORCID http://orcid.org/0000-0001-6311-7351
Shandy ShahabiDepartment of Chemistry & Biochemistry, University of California, San Diego, La Jolla, CA, USA.
Anand D JeyasekharanCancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Masahito IkawaResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.ORCID http://orcid.org/0000-0001-9859-6217
Yongliang ZhangDepartment of Microbiology and Immunology, Immunology Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.ORCID http://orcid.org/0000-0002-4964-1285
Shanshan Wu HowlandSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.ORCID http://orcid.org/0000-0003-4794-1564
Mai Chan LauSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore.
Vivien Ya-Fan WangFaculty of Health Sciences, University of Macau, Taipa, China.
Kong-Peng LamSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR)Immunos, Singapore, Singapore. lamkp@a-star.edu.sg.ORCID http://orcid.org/0000-0002-1316-4333
Vinay TergaonkarLaboratory of NF-κB Signalling, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore, Singapore. vinayt@imcb.a-star.edu.sg.ORCID http://orcid.org/0000-0001-9009-0844

Funding

Agency for Science, Technology and Research (A*STAR) HHP-IAF-PP:H22J1a0046Ministry of Health -Singapore (MOH) MOH-OFIRG21jun-0014Ministry of Health -Singapore (MOH) MOH-OFIRG24jan-0003National Research Foundation Singapore (National Research Foundation-Prime Minister's office, Republic of Singapore) NRF-CRP26-2021-0001
6 · The paper itself

Abstract

The NF-κB family comprises five transcription factors (RELA, RELB, C-REL, NF-κB1 (p50) and NF-κB2 (p52)) that form homo- or heterodimers among themselves to regulate gene expression by binding DNA. Here we show that p52 activates transcription without directly binding DNA but as a heterotetrameric complex with ETS1, a transcription factor outside the NF-κB family. By generating a knock-in mouse model (Nfkb2

Indexed as

B-LymphocytesGerminal CenterNF-kappa B p52 SubunitProto-Oncogene Protein c-ets-1AnimalsGene Expression RegulationGene Knock-In TechniquesHumansHypersensitivityImmunoglobulin EMiceMice, Inbred C57BLMice, KnockoutEts1 protein, mouseImmunoglobulin ENF-kappa B p52 SubunitProto-Oncogene Protein c-ets-1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.